Search Results - "Bendahl, P.‐O."

Refine Results
  1. 1

    Nomograms for preoperative prediction of axillary nodal status in breast cancer by Dihge, L., Bendahl, P.‐O., Rydén, L.

    Published in British journal of surgery (01-10-2017)
    “…Background Axillary staging in patients with breast cancer and clinically node‐negative disease is performed by sentinel node biopsy (SLNB). The aim of this…”
    Get full text
    Journal Article
  2. 2

    Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin by Gezelius, E, Flou Kristensen, A, Bendahl, P O, Hisada, Y, Risom Kristensen, S, Ek, L, Bergman, B, Wallberg, M, Falkmer, U, Mackman, N, Pedersen, S, Belting, M

    Published in PloS one (09-11-2018)
    “…Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Genomic profiling of malignant melanoma using tiling-resolution arrayCGH by JÖNSSON, G, DAHL, C, STAAF, J, SANDBERG, T, BENDAHL, P.-O, RINGNER, M, GULDBERG, P, BORG, A

    Published in Oncogene (12-07-2007)
    “…Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and clinical outcome are needed. We searched for chromosomal…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN) by Gezelius, E., Bendahl, P.O., Gonçalves de Oliveira, K., Ek, L., Bergman, B., Sundberg, J., Strandberg, K., Krämer, R., Belting, M.

    Published in European journal of cancer (1990) (01-09-2019)
    “…Coagulation activation is a hallmark of cancer, and anticoagulants have shown tumour-inhibiting properties. However, recent trials have failed to demonstrate…”
    Get full text
    Journal Article
  7. 7

    AIB1 is a predictive factor for tamoxifen response in premenopausal women by Alkner, S., Bendahl, P.-O., Grabau, D., Lövgren, K., Stål, O., Rydén, L., Fernö, M.

    Published in Annals of oncology (01-02-2010)
    “…Clinical trials implicate the estrogen receptor (ER) coactivator amplified in breast cancer 1 (AIB1) to be a prognostic and a treatment-predictive factor,…”
    Get full text
    Journal Article
  8. 8

    Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer by Majid, S, Bendahl, P-O, Huss, L, Manjer, J, Rydén, L, Dihge, L

    Published in BJS open (07-05-2021)
    “…Abstract Background Axillary staging via sentinel lymph node biopsy (SLNB) is performed for clinically node-negative (N0) breast cancer patients. The Skåne…”
    Get full text
    Journal Article
  9. 9

    Adjuvant radiotherapy of women with breast cancer – Information, support and side-effects by Sjövall, K, Strömbeck, G, Löfgren, A, Bendahl, P.-O, Gunnars, B

    “…Abstract The aim of this study was to 1) examine the occurrence and burden of side effects over time in the period after post surgical adjuvant radiotherapy in…”
    Get full text
    Journal Article
  10. 10

    Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates by DELLSON, P., NILBERT, M., BENDAHL, P-O., MALMSTRÖM, P., CARLSSON, C.

    Published in European journal of cancer care (01-07-2011)
    “…DELLSON P., NILBERT M., BENDAHL P‐O., MALMSTRÖM P. & CARLSSON C. (2010) European Journal of Cancer Care
Towards optimised information about clinical trials;…”
    Get full text
    Journal Article
  11. 11

    S-Phase Fraction and Urokinase Plasminogen Activator Are Better Markers for Distant Recurrences Than Nottingham Prognostic Index and Histologic Grade in a Prospective Study of Premenopausal Lymph Node–Negative Breast Cancer by MALMSTRÖM, P, BENDAHL, P.-O, BOIESEN, P, BRÜNNER, N, IDVALL, I, FERNÖ, M

    Published in Journal of clinical oncology (01-04-2001)
    “…Histologic grade, Nottingham Prognostic Index (NPI), estrogen receptor (ER) and progesterone receptor (PgR) status, and tumor size have previously been shown…”
    Get full text
    Journal Article
  12. 12

    Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial by Ek, L., Gezelius, E., Bergman, B., Bendahl, P.O., Anderson, H., Sundberg, J., Wallberg, M., Falkmer, U., Verma, S., Belting, M.

    Published in Annals of oncology (01-02-2018)
    “…Coagulation activation and venous thromboembolism (VTE) are hallmarks of malignant disease and represent a major cause of morbidity and mortality in cancer…”
    Get full text
    Journal Article
  13. 13

    Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study by Holten-Andersen, M., Christensen, I.J., Nilbert, M., Bendahl, P.O., Nielsen, H.J., Brünner, N., Fernebro, E.

    Published in European journal of cancer (1990) (01-01-2004)
    “…The level of the tissue inhibitor of metalloproteinases 1 (TIMP-1) has previously been demonstrated to predict the survival of early stage colorectal cancer…”
    Get full text
    Journal Article
  14. 14

    Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer by Gulis, K., Rydén, L., Bendahl, P. O., Svensjö, T.

    Published in World journal of surgery (01-05-2021)
    “…Background Breast-reduction techniques are increasingly used in oncoplastic breast surgery. Bilateral therapeutic mammoplasty has the benefit of decreasing…”
    Get full text
    Journal Article
  15. 15

    St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study by Narbe, U, Bendahl, P-O, Fernö, M, Ingvar, C, Dihge, L, Rydén, L

    Published in British journal of surgery (01-12-2021)
    “…The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omission of completion axillary lymph node dissection (cALND), regardless of…”
    Get full text
    Journal Article
  16. 16

    A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy by Gulis, K., Ellbrant, J., Svensjö, T., Skarping, I., Vallon-Christersson, J., Loman, N., Bendahl, P.O., Rydén, L.

    Published in European journal of surgical oncology (01-07-2023)
    “…Neoadjuvant chemotherapy (NAC) is an established treatment option for early breast cancer, potentially downstaging the tumor and increasing the eligibility for…”
    Get full text
    Journal Article
  17. 17

    Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes by Loman, Niklas, Johannsson, Oskar, Bendahl, Pär‐Ola, Borg, Åke, Fernö, Mårten, Olsson, Håkan

    Published in Cancer (15-07-1998)
    “…BACKGROUND The expression of steroid receptors is a common feature of both male and female breast carcinomas and is also one of the most important prognostic…”
    Get full text
    Journal Article
  18. 18

    St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up by Falck, A. K., Röme, A., Fernö, M., Olsson, H., Chebil, G., Bendahl, P. O., Rydén, L.

    Published in British journal of surgery (01-04-2016)
    “…Background Diagnosis by screening mammography is considered an independent positive prognostic factor, although the data are not fully in agreement. The aim of…”
    Get full text
    Journal Article
  19. 19

    Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer by Fredstorp-Lidebring, M, Bendahl, P.-O, Brünner, N, Casslén, B, Högberg, T, Långström-Einarsson, E, Willén, R, Fernö, M

    Published in European journal of cancer (1990) (01-12-2001)
    “…Components of the urokinase plasminogen activator (u-PA) system are involved in the metastatic process, and have accordingly been associated with clinical…”
    Get full text
    Journal Article
  20. 20

    Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data by Ellbrant, J, Gulis, K, Plasgård, E, Svensjö, T, Bendahl, P O, Rydén, L

    Published in BJS open (01-10-2021)
    “…Positive margins after breast-conserving surgery (BCS) and subsequent second surgery are associated with increased costs and patient discomfort. The aim of…”
    Get full text
    Journal Article